Scientist I - AOC Bioconjugation

Job Description

Job Description

Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides.
This unique combination is designed to allow selective targeting of the underlying genetic drivers of disease that were previously undruggable. Through targeted, non-viral delivery of siRNA to cardiac tissues, our approach has the potential to overcome key limitations of nonspecific viral and nanoparticle-based delivery systems, including challenges related to tissue specificity, immunogenicity, and redosing.

 
Position Overview:

We are seeking a hands-on Scientist I to join our Discovery Chemistry team, focused on the design, synthesis, purification, and characterization of antibody-oligonucleotide conjugates (AOCs) that deliver siRNA payloads selectively to cardiomyocytes. This bench-based role suits a bioconjugation chemist who wants to help advance a differentiated RNA-delivery platform, working closely with Biology, Developmental Sciences, Analytical, and Technical Development colleagues to advance candidate AOCs from discovery through IND-enabling studies.

Responsibilities:

• Synthesize, purify, and characterize antibody-oligonucleotide conjugates (AOCs) in support of discovery and early development programs.
• Develop, optimize, and support CDMO tech transfer of conjugation and purification processes to improve throughput, reproducibility, and product quality.
• Develop analytical methods to characterize the bioconjugation process intermediates and products, such as IEX, HIC, RP-HPLC, and LC-MS.
• Design, synthesize, and evaluate linkers for conjugation efficiency, stability, and activity.
• Collaborate cross-functionally with discovery and development teams to advance AOCs toward IND-enabling activities.
• Stay current with literature relating to bioconjugation, oligonucleotide therapeutics, and emerging technologies for cardiomyocyte delivery.
• Set up, maintain, and troubleshoot lab instruments to ensure continuous smooth operation. 
• Maintain detailed, compliant records in an electronic lab notebook (ELN) and present data and conclusions at internal project team meetings.

Education and Experience Requirements:

• Ph.D. in Chemistry, Chemical Biology, Biochemistry, or a related discipline, with 0–2 years of relevant postdoctoral or industry experience; or
• M.S. in a related discipline with 3–6 years of relevant industry experience; or
• B.S./B.A. in a related discipline with 6–9 years of relevant industry experience.
• Hands-on experience with bioconjugation chemistry (e.g., antibody-drug conjugate, antibody-oligonucleotide conjugate, peptide conjugates or related biomolecule conjugation approaches).
• Working knowledge of oligonucleotide chemistry and/or monoclonal antibody structure and handling.
• Experience with protein/bioconjugate purification techniques (HIC, SEC, IEX, affinity, and/or mixed-mode chromatography).
• Proficiency with analytical characterization methods (HPLC-based methods, CE-SDS, icIEF, LC-MS, UV-Vis).
• Strong record-keeping, problem-solving, and attention to detail.
• Effective written and verbal communication skills, with the ability to present data cross-functionally. 

What We Provide: 

• The base salary range for this role is $128,000-$142,000. The final compensation will be commensurate with such factors as relevant experience, skillset, internal equity and market factors.
• Atrium offers competitive compensation and benefits which include stock options & RSUs, as well as a 401(k) with an employer match. In addition, the comprehensive wellness program includes coverage for medical, dental, vision, LTD, and unlimited of time off including summer & winter breaks.
• A commitment to learning and development which includes a variety of programming internally developed by and for Atrium employees, opportunities for job-specific training offered by industry, and an education reimbursement program.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses and identifying potential inconsistencies or verification signals in application materials based on available information. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.